NCT03213522

Brief Summary

The purpose of this study is to determine the efficacy of CST for the treatment of LUTS in patients with MS and evaluate the acute effects compared to PFPT. A. Objectives To examine the effect of CST as compared to PFPT on QOL, SEMG resting biofeedback readings, and PVR ultrasonography measures in patients with MS and LUTS. B. Hypotheses / Research Question(s) It is hypothesized that patients who receive CST will demonstrate improved QOL, bladder control and ability to empty bladder as compared to those who receive PFPT.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 10, 2017

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 11, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2018

Completed
Last Updated

July 11, 2017

Status Verified

July 1, 2017

Enrollment Period

12 months

First QC Date

April 17, 2017

Last Update Submit

July 7, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • PFDI-20

    Pelvic floor distress inventory self-report questionnaire

    Change from baseline PFDI-20 after six weeks of intervention

  • PFIQ-7

    Pelvic floor incontinence questionnaire self-report

    Change from baseline PFIQ-7 after six weeks of intervention

Secondary Outcomes (9)

  • MSQOL-54

    Change from baseline MSQOL-54 after six weeks of intervention

  • Post void residual volume

    Change from baseline PVR after six weeks of intervention

  • Resting SEMG

    Change from baseline Resting SEMG after six weeks of intervention

  • Systolic BP

    Change from baseline Systolic BP after six weeks of intervention

  • Systolic BP

    Change from pre-intervention to post-intervention at each of six intervention sessions

  • +4 more secondary outcomes

Study Arms (2)

Pelvic Floor Physical Therapy

ACTIVE COMPARATOR

PFPT group will be treated/educated with/on therapeutic exercise, which includes, but not limited to, the pelvic brace, pelvic floor muscle exercise, and diaphragmatic breathing. If the patient is presenting with hypertonia of lower extremity muscles and/or muscles connecting to or part of the pelvic floor, the patient may be instructed on gentle static stretching and/or treated with passive stretching and diaphragmatic breathing.

Procedure: Pelvic Floor Physical Therapy

CranioSacral Therapy

ACTIVE COMPARATOR

Modified Upledger Institute 10-step protocol. Sequence of hand placements (for this protocol)/type of intervention which will mirror many of the treatment sequences described in the systematic review by Jakel and von Hauenschild (2012).

Procedure: Craniosacral Therapy

Interventions

Educating the PFPT group on therapeutic exercise, which includes, but not limited to, the pelvic brace, pelvic floor muscle exercise, and diaphragmatic breathing. If the patient is presenting with hypertonia of lower extremity muscles and/or muscles connecting to or part of the pelvic floor, the patient may be instructed on gentle static stretching and/or treated with passive stretching and diaphragmatic breathing.

Also known as: Bladder training, Pelvic floor muscle training, Prompted voiding
Pelvic Floor Physical Therapy

Modified Upledger Institute 10-step protocol.

Also known as: Osteopathic manipulation, Visceral manipulation
CranioSacral Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Multiple Sclerosis
  • Currently have the following symptoms for at least three (3) months or longer: frequent urination, increased urge to urinate, nighttime urination, loss/leakage of urine with or without activity, and/or problems emptying your bladder.

You may not qualify if:

  • Unable or unwilling to give consent to be treated
  • Unable or unwilling to cover your portion of physical therapy treatment (i.e. co-pays and/or deductibles)
  • Cannot speak or read English
  • Have NOT had any urinary symptoms for at least three (3) months
  • Do not have Multiple Sclerosis; or have NOT been diagnosed with Multiple Sclerosis
  • Take medication to treat your urinary symptoms; or have taken medication in the past three (3) months to treat your urinary symptoms
  • Use an indwelling catheter (i.e. tube inserted into your bladder for continuous urine drainage); or you require intermittent catheterization
  • Currently are experiencing any of the following: shooting or radiating pain in your back or abdomen; pain that is not relieved with body position and/or medication; nausea; decreased appetite; pain with bowel movements or urination; and/or any symptom that is new and/or of unexplained onset (i.e. you do not know why it started or when it started)
  • Currently have cancer/tumors (i.e. tumors in the spine, brain, pelvis, etc.) and/or aneurysms (i.e. abdominal aortic aneurysm)
  • Received Botox injections in the past three (3) months
  • Received Pelvic Floor Physical Therapy and/or Craniosacral Therapy in the past three (3) months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CentraState Medical Center

Freehold, New Jersey, 07728, United States

RECRUITING

MeSH Terms

Conditions

Multiple SclerosisUrinary IncontinenceUrinary Bladder, Overactive

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsUrinary Bladder Diseases

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Danielle T Robbins, DPT

    CentraState Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Danielle T Robbins, DPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2017

First Posted

July 11, 2017

Study Start

April 10, 2017

Primary Completion

April 9, 2018

Study Completion

April 9, 2018

Last Updated

July 11, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations